阻塞性冠状动脉疾病-话题@MedSci

#阻塞性冠状动脉疾病#

6篇内容 | 1084人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2284968, encodeId=37eb22849680f, content=<a href='/topic/show?id=3447e83873c' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入术#</a> <a href='/topic/show?id=b6222320322' target=_blank style='color:#2F92EE;'>#主动脉瓣置换术#</a> <a href='/topic/show?id=ffcf2114849' target=_blank style='color:#2F92EE;'>#严重主动脉瓣狭窄#</a> <a href='/topic/show?id=eb6b9e65541' target=_blank style='color:#2F92EE;'>#阻塞性冠状动脉疾病#</a> <a href='/topic/show?id=1cef13081efb' target=_blank style='color:#2F92EE;'>#分数流储备#</a>, objectTitle=Lancet：突破传统手术局限！PCI联合TAVI治疗重度主动脉瓣狭窄，1年复合不良事件显著低于SAVR+CABG，住院时间缩短, objectType=article, longId=902601, objectId=7eba90260192, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250926/1758848742636_8538692.png, objectUrl=/article/show_article.do?id=7eba90260192, replyNumber=0, likeNumber=12, createdTime=2025-10-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7eba90260192, moduleTitle=Lancet：突破传统手术局限！PCI联合TAVI治疗重度主动脉瓣狭窄，1年复合不良事件显著低于SAVR+CABG，住院时间缩短, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7eba90260192)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1466530, encodeId=16ec1466530ff, content=<a href='/topic/show?id=eb6b9e65541' target=_blank style='color:#2F92EE;'>#阻塞性冠状动脉疾病#</a>, objectTitle=JAHA：疑似冠状动脉疾病患者心外膜脂肪量与阻塞性冠状动脉疾病风险相关, objectType=article, longId=207889, objectId=67d620e88950, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67d620e88950, replyNumber=0, likeNumber=77, createdTime=2021-03-06, rootId=0, userName=charl1234569, userId=64696828888, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67d620e88950, moduleTitle=JAHA：疑似冠状动脉疾病患者心外膜脂肪量与阻塞性冠状动脉疾病风险相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67d620e88950)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466529, encodeId=5cf314665297d, content=<a href='/topic/show?id=eb6b9e65541' target=_blank style='color:#2F92EE;'>#阻塞性冠状动脉疾病#</a>, objectTitle=Catheter Cardiovasc Interv：微血管阻力指数评估罗伐他汀对胸痛且无阻塞性冠状动脉疾病的女性微血管功能的影响, objectType=article, longId=201319, objectId=0a6920131931, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a6920131931, replyNumber=0, likeNumber=86, createdTime=2020-09-29, rootId=0, userName=charl1234569, userId=64696828888, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a6920131931, moduleTitle=Catheter Cardiovasc Interv：微血管阻力指数评估罗伐他汀对胸痛且无阻塞性冠状动脉疾病的女性微血管功能的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a6920131931)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466528, encodeId=5de1146652880, content=<a href='/topic/show?id=eb6b9e65541' target=_blank style='color:#2F92EE;'>#阻塞性冠状动脉疾病#</a>, objectTitle=JAHA：甘油三酯和甘油三酯/HDL比率可预测非阻塞性冠状动脉疾病女性主要不良心血管结局, objectType=article, longId=164960, objectId=788f164960fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=788f164960fa, replyNumber=0, likeNumber=85, createdTime=2019-04-26, rootId=0, userName=charl1234569, userId=64696828888, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=788f164960fa, moduleTitle=JAHA：甘油三酯和甘油三酯/HDL比率可预测非阻塞性冠状动脉疾病女性主要不良心血管结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=788f164960fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466527, encodeId=768c146652e43, content=<a href='/topic/show?id=eb6b9e65541' target=_blank style='color:#2F92EE;'>#阻塞性冠状动脉疾病#</a>, objectTitle=2019 AHA科学声明：无阻塞性冠状动脉疾病心肌梗死患者的诊断和管理, objectType=article, longId=164371, objectId=88041643e15b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88041643e15b, replyNumber=0, likeNumber=75, createdTime=2019-04-17, rootId=0, userName=charl1234569, userId=64696828888, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88041643e15b, moduleTitle=2019 AHA科学声明：无阻塞性冠状动脉疾病心肌梗死患者的诊断和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88041643e15b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466526, encodeId=956b146652611, content=<a href='/topic/show?id=eb6b9e65541' target=_blank style='color:#2F92EE;'>#阻塞性冠状动脉疾病#</a>, objectTitle=JAHA：阻塞性冠状动脉疾病患者痛风与长期心血管结局的关联, objectType=article, longId=146907, objectId=ab3314690e8d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab3314690e8d, replyNumber=0, likeNumber=142, createdTime=2018-08-19, rootId=0, userName=charl1234569, userId=64696828888, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab3314690e8d, moduleTitle=JAHA：阻塞性冠状动脉疾病患者痛风与长期心血管结局的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab3314690e8d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1466525, encodeId=31b214665250b, content=<a href='/topic/show?id=eb6b9e65541' target=_blank style='color:#2F92EE;'>#阻塞性冠状动脉疾病#</a>, objectTitle=JAHA：有症状糖尿病患者但无阻塞性冠状动脉疾病患者雷诺拉嗪疗效如何？, objectType=article, longId=98105, objectId=a233981053f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a233981053f, replyNumber=0, likeNumber=86, createdTime=2017-05-09, rootId=0, userName=charl1234569, userId=64696828888, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a233981053f, moduleTitle=JAHA：有症状糖尿病患者但无阻塞性冠状动脉疾病患者雷诺拉嗪疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a233981053f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

阻塞性冠状动脉疾病

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入术# #主动脉瓣置换术# #严重主动脉瓣狭窄# #阻塞性冠状动脉疾病# #分数流储备#

Lancet：突破传统手术局限！PCI联合TAVI治疗重度主动脉瓣狭窄，1年复合不良事件显著低于SAVR+CABG，住院时间缩短

2025-10-16发表于上海

charl1234569 (审核中...)

前往app查看评论内容

#阻塞性冠状动脉疾病#

JAHA：疑似冠状动脉疾病患者心外膜脂肪量与阻塞性冠状动脉疾病风险相关

2021-03-06

charl1234569 (审核中...)

前往app查看评论内容

#阻塞性冠状动脉疾病#

Catheter Cardiovasc Interv：微血管阻力指数评估罗伐他汀对胸痛且无阻塞性冠状动脉疾病的女性微血管功能的影响

2020-09-29

charl1234569 (审核中...)

前往app查看评论内容

#阻塞性冠状动脉疾病#

JAHA：甘油三酯和甘油三酯/HDL比率可预测非阻塞性冠状动脉疾病女性主要不良心血管结局

2019-04-26

charl1234569 (审核中...)

前往app查看评论内容

#阻塞性冠状动脉疾病#

2019 AHA科学声明：无阻塞性冠状动脉疾病心肌梗死患者的诊断和管理

2019-04-17

charl1234569 (审核中...)

前往app查看评论内容

#阻塞性冠状动脉疾病#

JAHA：阻塞性冠状动脉疾病患者痛风与长期心血管结局的关联

2018-08-19

charl1234569 (审核中...)

前往app查看评论内容

#阻塞性冠状动脉疾病#

JAHA：有症状糖尿病患者但无阻塞性冠状动脉疾病患者雷诺拉嗪疗效如何？

2017-05-09

科室
- - 订阅+
  - 更多科室
工具
服务